Skip to main content
News

Statistics published for all routine childhood vaccinations in England in 2019-20

• Coverage increased in most routine vaccinations - with MMR coverage at 24 months up for the first time in six years.
Date:
News type:
Press releases

Coverage1 for all routine childhood vaccinations2 administered to children under five in England in 2019-20 has been published today.

NHS Digital’s Childhood Vaccination Coverage Statistics contains information on vaccinations measured at the ages of 12 months, 24 months and five years. There are 14 measures3 of vaccination coverage. At a national level, coverage has increased for 12 of these.

Measles, Mumps and Rubella (MMR)4 vaccine

Coverage for the first dose of the MMR vaccine among children aged 24 months has increased from 90.3% in 2018-19 to 90.6% in 2019-20. The World Health Organization (WHO) target is 95%.

This is the first time in six years that MMR coverage in England has increased, following a peak of 92.7% in 2013-14.

Regional data5 shows an increase in coverage in six of the nine English regions in 2019-20 compared to the previous year. Coverage fell in the remaining three regions. The North East had the highest level of coverage at 95.1% and was the only region to exceed the national target of 95%. London had the lowest level of coverage in 2019-20 at 83.6% (up from 83.0% in 2018-19).

Across England, 94.5% of children aged five years had received the first dose of the MMR vaccine in 2019-20 – the same percentage as the previous year, and still below the 95% target. In 2019-20, eight out of nine regions achieved 95% coverage.

5-in-1 and 6-in-1 vaccines6

Coverage for the 5-in-1/6-in-1 vaccine, which protects against diphtheria, pertussis, tetanus, polio, disease caused by Haemophilus influenzae type b and hepatitis B, increased among children aged 12 months and five years, but decreased for children aged 24 months.

Coverage at 12 months increased from 92.1% in 2018-19 to 92.6% in 2019-20, but is still lower than its peak of 94.7% in 2012-13.

Among children aged 24 months, coverage was below the 95% target for the second consecutive year. It was 93.8% in 2019-20, compared to 94.2% in 2018-19. This decrease is influenced by the 12-month coverage in 2018-19.

For children aged five years, coverage was 95.2% in 2019-20 (meeting the target of 95% for the seventh consecutive year), up from 95.0% in 2018-19.

Other vaccinations

The report also includes coverage data for the pneumococcal disease (PCV), rotavirus, meningococcal group B (MenB), Hib booster and meningococcal group C vaccine (Hib/MenC) and children’s flu vaccines.

This year’s report includes data on the MenB booster vaccine7 as a National Statistic for the second time. England coverage at the age of 24 months was 88.7% in 2019-20 – up from 87.8% in 2018-19.

 

List of vaccinations, ages at which coverage is measured and coverage for past three years:

Vaccination

Age administered

Age measured

2019-20

2018-19

2017-18

Diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b(DTaP/IPV/Hib)*

8, 12 & 16 weeks

12 months

92.6

92.1

93.1

 

24 months

93.8

94.2

95.1

 

5 years

95.2

95.0

95.6

Pneumococcal disease (PCV)

8 & 16 weeks

12 months

93.2

92.8

93.3

Rotavirus

8 & 12 weeks

12 months

90.1

89.7

90.1

Meningococcal group B (MenB)

8 & 16 weeks

12 months

92.5

92.0

92.5

Haemophilus influenzae type b and meningococcal group C (Hib / MenC)

1 year

24 months

90.5

90.4

91.2

 

5 years

92.5

92.2

92.4

Measles/mumps/rubella (MMR)

1 year

24 months

90.6

90.3

91.2

 

 

5 years

94.5

94.5

94.9

Pneumococcal disease (PCV) booster

1 year

24 months

90.4

90.2

91.0

Meningococcal group B (MenB) booster

1 year

24 months

88.7

87.8

-

Diphtheria, tetanus, pertussis, and polio (DTaP/IPV) booster

3 yrs 4 months to 5 yrs

5 years

85.4

84.8

85.6

Measles/mumps/rubella (MMR) second dose

3 yrs 4 months to 5 yrs

5 years

86.8

86.4

87.2

* In 2019-20, for the 12-month cohort, coverage is evaluated against the 6-in-1 hexavalent vaccine. DTAP/IPV/Hib. Other measures reflect coverage for the 5-in-1 pentavalent vaccine.


Read the full report

Childhood Vaccination Coverage Statistics

ENDS

 

Notes for editors

    1. Coverage is defined as the number of persons immunised as a proportion of the eligible population. The formula for the calculation of coverage is: (Total number of eligible persons immunised / Total number of persons in eligible population) x 100
    2. Vaccinations measured at 12 months, 24 months or 5 years in England in 2019-20, compared to the previous year. Some vaccinations have their coverage measured at all of these ages while others are just measured at one or two of them. The increase ranged in size from 0.2 to 0.9 percentage points. Coverage for MMR1 at 5 years remained the same as the previous year. The only coverage measure to decrease was the 5-in-1 / 6-in-1 at 24 months. See page 11 of the report for more information.
    3. Data on 14 routine childhood vaccination measurements is included in this report; these measurements relate to 10 vaccinations. In addition, data are published for two selective neonatal vaccination programmes (BCG and hepatitis B) and flu.
    4. The MMR vaccine was introduced in 1988 and the highest level of coverage at 24 months was 92.7% in 2013-14. The lowest was in 2003-04 when coverage was 79.9%.
    5. The nine regions are: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East and South West.
    6. In September 2017, the 5-in-1 vaccine was replaced with a 6-in-1 vaccine, adding protection against hepatitis B for all babies born after 1 August 2017.
      1. Any children born or vaccinated in 2018-19 would have received the 6-in-1. This represents the 12-month cohort in the 2019-20 report.
      2. Any children vaccinated in 2017-18 will have received either the 5-in-1 vaccine or the 6-in-1 vaccine, depending on when in the year they were vaccinated. For the purposes of this report, children receiving either of these vaccinations will be included within the 5-in-1 numbers. This change mainly affects the 24-month cohort who were all born in 2017-18, it does not significantly impact the five-year age cohorts as most of these children will have been vaccinated prior to the introduction of the 6-in-1 vaccine.
    7. Meningococcal group B (MenB) vaccine was introduced into the routine immunisation programme in September 2015 and is offered at 8 and 16 weeks of age with a booster after the first birthday.
    8. Further information on vaccinations is available on the NHS website.
    9. For media enquiries please contact media@nhsdigital.nhs.net or telephone 0300 30 33 888. Follow us on Twitter: @NHSDigital

Share this page

Contact us

Media enquiries
Last edited: 24 September 2020 8:12 am